Infliximab therapy for Netherton syndrome: A case report

Ângela Roda; Maria Mendonça-Sanches; Ana Rita Travassos; Luís Soares-de-Almeida; Dieter Metze

doi:10.1016/j.jdcr.2017.07.019

Infliximab therapy for Netherton syndrome: A case report

JAAD Case Rep. 2017 Nov 6;3(6):550-552. doi: 10.1016/j.jdcr.2017.07.019. eCollection 2017 Nov.

Authors

Ângela Roda¹, Maria Mendonça-Sanches¹, Ana Rita Travassos¹, Luís Soares-de-Almeida^{1

2

3}, Dieter Metze⁴

Affiliations

¹ Centro Hospitalar Lisboa Norte EPE, Hospital de Santa Maria, Serviço de Dermatologia, Lisboa, Portugal.
² Universidade de Lisboa, Faculdade de Medicina, Clínica Universitária de Dermatologia de Lisboa, Lisboa, Portugal.
³ Universidade de Lisboa, Faculdade de Medicina, Instituto de Medicina Molecular, Lisboa, Portugal.
⁴ Department of Dermatology, University of Münster, Münster, Germany.

No abstract available

Keywords: KLK5, kallikrein 5; NS, Netherton syndrome; Netherton syndrome; PAR2, protease-activated receptor 2; SPINK5, serine protease inhibitor Kazal type 5; TNF, tumor necrosis factor; TSLP, thymic stromal lymphopoietin; Th, helper T cell; ichthyosis; infliximab; tumor necrosis factor-α.

Publication types

Case Reports